Canopy Growth (CGC) Shares Outstanding (Weighted Average) (2017 - 2025)

Canopy Growth's (CGC) quarterly Shares Outstanding (Weighted Average) came in at $11.1 million in Q4 2025, little changed year-on-year from $11.1 million in Q4 2024, and down 94.42% quarter-over-quarter from $199.1 million in Q3 2025.

Canopy Growth (CGC) Shares Outstanding (Weighted Average) (2017 - 2025) Analysis & Trends

Canopy Growth has disclosed Shares Outstanding (Weighted Average) across 9 years of filings, most recently posting $11.1 million for Q4 2025.

  • Shares Outstanding (Weighted Average) for Q4 2025 came in at $11.1 million, changed 0.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.1 million (changed 0.36% YoY), and the FY2025 annual result was $10.8 million, up 39.12% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $11.1 million for Q4 2025 at Canopy Growth, down from $199.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $312.5 million in Q2 2022 to a low of $7.8 million in Q1 2024.
  • The 5-year median for Shares Outstanding (Weighted Average) is $49.5 million (2023), against an average of $100.8 million.
  • Across the five-year window, Shares Outstanding (Weighted Average) plunged 90.8% in 2021 and soared 440.11% in 2024, its largest moves.
  • Canopy Growth's Shares Outstanding (Weighted Average) stood at $309.7 million in 2021, then plunged by 89.22% to $33.4 million in 2022, then jumped by 82.41% to $60.9 million in 2023, then tumbled by 81.71% to $11.1 million in 2024, then fell by 0.36% to $11.1 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $11.1 million (Q4 2025), $199.1 million (Q3 2025), and $135.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 100.50 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn 5.11 Bn
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 64.74 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 88.01 Mn
10 Canopy Growth 11.16 Mn -137.54 Mn 15.39 Mn 11.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 11.10 Mn
Sep 30, 2025 199.12 Mn
Jun 30, 2025 135.91 Mn
Mar 31, 2025 10.79 Mn
Dec 31, 2024 11.14 Mn
Sep 30, 2024 60.88 Mn
Jun 30, 2024 57.94 Mn
Mar 31, 2024 7.76 Mn
Dec 31, 2023 60.91 Mn
Sep 30, 2023 11.27 Mn
Jun 30, 2023 40.98 Mn
Mar 31, 2023 9.48 Mn
Dec 31, 2022 33.39 Mn
Sep 30, 2022 98.29 Mn
Jun 30, 2022 312.53 Mn
Mar 31, 2022 10.12 Mn
Dec 31, 2021 309.74 Mn
Sep 30, 2021 312.42 Mn
Jun 30, 2021 312.44 Mn
Mar 31, 2021 10.04 Mn